William C. Olivero

Neurosurgery
611 W Park St
Urbana, IL 61801

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Retraction Note to: RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas.

Retraction Note to: RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas.

Journal: Oncogene
Published: April 29, 2025

Retraction Note: Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.

Retraction Note: Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.

Journal: Oncogene
Published: April 29, 2025

Retraction Note: Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro.

Retraction Note: Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro.

Journal: Oncogene
Published: April 25, 2025

Retraction Note: Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences.

Retraction Note: Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences.

Journal: Oncogene
Published: April 11, 2025

Retraction Note: Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis.

Retraction Note: Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis.

Journal: Oncogene
Published: April 11, 2025

Retraction Note to: Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells.

Retraction Note to: Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells.

Journal: Oncogene
Published: April 11, 2025

Retraction Note: A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion.

Retraction Note: A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion.

Journal: Oncogene
Published: April 10, 2025

Retraction Note: Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis.

Retraction Note: Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis.

Journal: Oncogene
Published: April 10, 2025

Retraction Note: Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion.

Retraction Note: Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion.

Journal: Oncogene
Published: April 09, 2025

Retraction Note: Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas.

Retraction Note: Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas.

Journal: Oncogene
Published: April 09, 2025

Retraction Note: Activation of caspase-9 with irradiation inhibits invasion and angiogenesis in SNB19 human glioma cells.

Retraction Note: Activation of caspase-9 with irradiation inhibits invasion and angiogenesis in SNB19 human glioma cells.

Journal: Oncogene
Published: April 08, 2025

Retraction Note: Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells.

Retraction Note: Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells.

Journal: Oncogene
Published: April 04, 2025
Showing 1-12 of 27

Last Updated: 09/26/2026